m

Lockdown eases, central banks, oil, pharma and tech earnings

Start every week on the front foot with a preview of what’s on the global agenda




m

US and Chinese researchers team up for hunt into Covid origins

Scientists co-operate on search for Covid-19 origins despite charges Beijing is withholding data




m

Drugmakers race to scale up vaccine capacity

Funding bodies face a choice between established manufacturers and biotech upstarts




m

Fauci praises remdesivir after data show it speeds recovery

US-run trial of Gilead coronavirus therapy demonstrates ‘significant positive effect’




m

Remdesivir: Five things to know about the antiviral drug

Gilead’s potential coronavirus treatment stirs investor hopes but evidence on effectiveness is mixed




m

Dozens of existing drugs being tested as possible virus treatments

Research paper published in journal Nature identifies number of alternative treatments




m

Coronavirus vaccine: an epidemic of nationalism

First country to get a vaccine could have an economic as well as a health advantage




m

Gilead hopes to produce 1m courses of remdesivir by year’s end

Biotech group’s shares have soared this year on hopes drug could be used to treat coronavirus




m

FDA gives emergency authorisation to remdesivir

US-led trial shows positive results in hastening recovery time for coronavirus patients




m

How an unproven drug became a bellwether for global stocks

Investors have bet on Gilead’s remdesivir as solution to coronavirus crisis




m

Cost of vaccinating billions against Covid-19 put at more than $20bn

Sum far exceeds $8bn fundraising target at upcoming EU-led donors’ conference




m

Call to overhaul plasma rules to speed up potential virus therapy

Industry highlights bottlenecks in access to materials that are a possible Covid-19 treatment




m

FT Health: Combating Coronavirus

As researchers race to develop a coronavirus vaccine, we look at efforts to ensure that the world’s poor are not left behind — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistance




m

Will poor countries get the treatments they need?

Pharma and its critics agree government has a big role to play in ensuring fair access to Covid-19 remedies




m

From blood clots to ‘Covid toe’: the medical mysteries of coronavirus

The wide variety of Covid-19 symptoms seen by doctors is confounding the scientific community




m

Hydrogen energy projects win £30m UK funding

Schemes to look at cutting emissions in sectors such as transport in push to meet 2050 ‘net zero’ target




m

PG&E posts $3.6bn quarterly loss after wildfire settlement

California utility discloses $5bn pre-tax charge tied to claims




m

Philippines: Duterte takes aim at the oligarchs

The president has turned his populist fire on big business, but is he attacking corporate greed or political opponents?




m

Global investors warn S Korea’s Kepco over carbon emissions

State-backed utility under pressure as it plans to invest in new coal mines




m

Trump appointees vote to block US coal joint venture

Shares in Peabody Energy and Arch Coal fall sharply after regulatory action




m

Johnson revives onshore wind farms after 4-year ban

Policy reversal follows Cameron vow to rid UK of ‘unsightly’ structures




m

Green boost as £800m pledged for carbon capture

Climate campaigners say measures lack ambition to tackle crisis




m

How emergency planning has kept lights on and taps running

Energy, water and other utility groups keep services going despite lockdowns and cuts




m

Britain’s electricity demand falls by a tenth in lockdown

Decline leads to a drop in wholesale prices as businesses close




m

Energy groups seek help on payment holidays

Loan scheme worth up to £100m a month would allow suppliers to assist struggling customers




m

Electricity prices slump as businesses close across the US

Shutdowns likely to shift energy use from fossil fuels towards wind and solar




m

Things are not as dire as they might seem for Centrica

If lenders maintain support, the company’s balance sheet may not need an urgent fix




m

Intel: Moovit or lose it

Chipmaker likely to be interested in app’s traffic data rather than its customers




m

Telefónica/Liberty: rainy day dealmaking

Potential cost cuts should not be used as justification for a UK telecoms tie-up




m

Economic recovery: no favours from savers

British and American consumers are unlikely to ‘spend, spend, spend’ after the lockdowns




m

Failed M&A: band of hope

Buyers who get cold feet tend to have the advantage but jilted targets can still extract value




m

Lex Midweek Letter: Amazon’s May Day mayday

Customers and investors may appear immune to staff complaints but regulators have not lost interest




m

Shopify: customer service

Retail services group’s new Shop app needs a price gimmick to lure buyers in




m

New York Times: eclectic current

The website this week notched up 240m unique visitors




m

Match: relationship goals

Finding love in a time of corona is tricky, converting activity into paid accounts is harder yet




m

What will the UK property market look like after lockdown?

Join our live discussion with buying agent Henry Pryor on Friday May 8 at 12 and 5pm UK time




m

Colony Capital reveals $3.2bn default on portfolio company loans

Trump ally Tom Barrack’s investment group in talks with lenders over hotel and nursing home debt




m

Coronavirus tracked: the latest figures as countries fight to contain the pandemic

The FT analyses the scale of outbreaks and the number of deaths around the world




m

Dollar’s long-term prospects turn gloomy, say analysts

Interest rate cuts and massive fiscal stimulus are expected to weigh on the greenback




m

Turkey slashes rates in bid to shore up economy against coronavirus

Eighth consecutive cut could heap fresh pressure on already struggling lira




m

Swiss central bank suffers record loss in market rout

First-quarter volatility deals $39bn blow to SNB as it steps up fight for Swiss franc




m

Credit risk inside the hall of mirrors

Mike Mackenzie’s daily analysis of what’s moving global markets




m

Policy response determines plenty

Mike Mackenzie’s daily analysis of what’s moving global markets




m

Turkish lira succumbs to pressure and weakens past 7 to dollar

Currency softens beyond key level as investors brace themselves for more interest rate cuts




m

Stumbling into May after running too fast

Mike Mackenzie’s daily analysis of what’s moving global markets




m

Will the Bank of England announce more QE?

Market Questions is the FT’s guide to the week ahead




m

Can governments afford the debts piling up to stabilise economies?

Two experts debate the long-term impact on inflation of the Covid-19 rescue packages




m

Iran’s parliament backs move to cut 4 zeros from its currency

Rial to be changed to the toman after five decades of inflation




m

UK pound slips more than 1% in first two trading days of May

Sterling under pressure from US-China angst and renewed Brexit concerns




m

Facebook’s Libra appoints Bush-era terrorism finance tsar as first chief

Stuart Levey, known for tough enforcement of sanctions on Iran, will head digital currency project